Antibody rise observed in lactating mothers and in their breast milk Long-term goal is to provide protection to infants through passive antibody transfer SOUTH SAN FRANCISCO, Calif., April 30,...
SOUTH SAN FRANCISCO, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, will present at the World...
SOUTH SAN FRANCISCO, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the Company or Vaxart) today announced that the Compensation Committee of the Board of Directors...
Vaxart Provides Business Update and Reports Full Year 2023 Financial Results
Vaxart to Host Full Year 2023 Business Update and Financial Results Conference
Vaxart Appoints Steven Lo as President, Chief Executive Officer, and Director
Data served as foundation for current vaccine candidate for planned Phase 2 research Vaxart vaccine candidates elicited strong antigen-specific serum IgG and IgA with neutralizing activity...
Vaxart Receives $9.27 Million BARDA Project NextGen Award
Vaxart, Inc. Announces Management Change
Vaxart Announces $10.0M Registered Direct Offering with RA Capital Management